These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 2460346)
1. Anti-(Arg-Gly-Asp-Ser) antibody and its interaction with fibronectin, fibrinogen and platelets. Cierniewski CS; Swiatkowska M; Poniatowski J; Niewiarowska J Eur J Biochem; 1988 Oct; 177(1):109-15. PubMed ID: 2460346 [TBL] [Abstract][Full Text] [Related]
2. The tetrapeptide analogue of the cell attachment site of fibronectin inhibits platelet aggregation and fibrinogen binding to activated platelets. Gartner TK; Bennett JS J Biol Chem; 1985 Oct; 260(22):11891-4. PubMed ID: 2995350 [TBL] [Abstract][Full Text] [Related]
3. The effect of Arg-Gly-Asp-containing peptides on fibrinogen and von Willebrand factor binding to platelets. Plow EF; Pierschbacher MD; Ruoslahti E; Marguerie GA; Ginsberg MH Proc Natl Acad Sci U S A; 1985 Dec; 82(23):8057-61. PubMed ID: 3877935 [TBL] [Abstract][Full Text] [Related]
4. [Conformational changes of the platelet membrane glycoprotein IIb-IIIa complex stimulated by a monoclonal antibody to the N-terminal segment of glycoprotein IIIa]. Khaspekova SG; Vyzova TV; Lukin VV; Tikhomirov OIu; Berndt M; Kouns W; Mazurov AV Biokhimiia; 1996 Mar; 61(3):412-28. PubMed ID: 8724599 [TBL] [Abstract][Full Text] [Related]
5. The fibrinogen-derived peptide (RGDS) prevents proteolytic degradation of protein kinase C in platelets by inhibiting platelet aggregation. Krishnamurthi S; Dickens TA; Patel Y; Wheeler-Jones CP; Kakkar VV Biochem Biophys Res Commun; 1989 Sep; 163(3):1256-64. PubMed ID: 2783136 [TBL] [Abstract][Full Text] [Related]
6. Synthetic peptides derived from fibrinogen and fibronectin change the conformation of purified platelet glycoprotein IIb-IIIa. Parise LV; Helgerson SL; Steiner B; Nannizzi L; Phillips DR J Biol Chem; 1987 Sep; 262(26):12597-602. PubMed ID: 2957377 [TBL] [Abstract][Full Text] [Related]
7. KRDS, a new peptide derived from human lactotransferrin, inhibits platelet aggregation and release reaction. Mazoyer E; Lévy-Toledano S; Rendu F; Hermant L; Lu H; Fiat AM; Jollès P; Caen J Eur J Biochem; 1990 Nov; 194(1):43-9. PubMed ID: 2174781 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of platelet adhesion to fibronectin, fibrinogen, and von Willebrand factor substrates by a synthetic tetrapeptide derived from the cell-binding domain of fibronectin. Haverstick DM; Cowan JF; Yamada KM; Santoro SA Blood; 1985 Oct; 66(4):946-52. PubMed ID: 3876125 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of platelet function with synthetic peptides designed to be high-affinity antagonists of fibrinogen binding to platelets. Ruggeri ZM; Houghten RA; Russell SR; Zimmerman TS Proc Natl Acad Sci U S A; 1986 Aug; 83(15):5708-12. PubMed ID: 3016716 [TBL] [Abstract][Full Text] [Related]
10. The Ser-Arg-Tyr-Asp region of the major surface glycoprotein of Leishmania mimics the Arg-Gly-Asp-Ser cell attachment region of fibronectin. Soteriadou KP; Remoundos MS; Katsikas MC; Tzinia AK; Tsikaris V; Sakarellos C; Tzartos SJ J Biol Chem; 1992 Jul; 267(20):13980-5. PubMed ID: 1629196 [TBL] [Abstract][Full Text] [Related]
11. Identification of two distinct regions within the binding sites for fibrinogen and fibronectin on the IIb-IIIa human platelet membrane glycoprotein complex by monoclonal antibodies P2 and P4. McGregor JL; McGregor L; Bauer AS; Catimel B; Brochier J; Dechavanne M; Clemetson KJ Eur J Biochem; 1986 Sep; 159(3):443-9. PubMed ID: 2944746 [TBL] [Abstract][Full Text] [Related]
12. Effects of the cell adhesion peptide, Arg-Gly-Asp-Ser, on responses of washed platelets from humans, rabbits, and rats. Harfenist EJ; Packham MA; Mustard JF Blood; 1988 Jan; 71(1):132-6. PubMed ID: 3334894 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of fibronectin binding to platelets by proteolytic fragments and synthetic peptides which support fibroblast adhesion. Ginsberg M; Pierschbacher MD; Ruoslahti E; Marguerie G; Plow E J Biol Chem; 1985 Apr; 260(7):3931-6. PubMed ID: 3980461 [TBL] [Abstract][Full Text] [Related]
14. Modulation of an RGDS binding site on the platelet membrane glycoprotein IIb-IIIa complex. Santoro SA; Lawing WJ Biochem Biophys Res Commun; 1989 Apr; 160(1):189-95. PubMed ID: 2712830 [TBL] [Abstract][Full Text] [Related]
15. The synthetic RGDS peptide inhibits the binding of fibrinogen lacking intact alpha chain carboxyterminal sequences to human blood platelets. Peerschke EI; Galanakis DK Blood; 1987 Mar; 69(3):950-2. PubMed ID: 3814824 [TBL] [Abstract][Full Text] [Related]
16. Role of the gamma chain Ala-Gly-Asp-Val and Aalpha chain Arg-Gly-Asp-Ser sites of fibrinogen in coaggregation of platelets and fibrinogen-coated beads. Liu Q; Rooney MM; Kasirer-Friede A; Brown E; Lord ST; Frojmovic MM Biochim Biophys Acta; 1998 Jun; 1385(1):33-42. PubMed ID: 9630497 [TBL] [Abstract][Full Text] [Related]
17. A monoclonal antibody to the alpha 2 integrin subunit cross-reacts with RGD-dependent epitopes in fibrinogen. Jaspers M; Vekemans S; Carmeliet G; van Leuven F; de Strooper B; Deckmyn H; Cassiman JJ Hybridoma; 1993 Aug; 12(4):467-74. PubMed ID: 7503943 [TBL] [Abstract][Full Text] [Related]
19. Mechanism of action of the antiplatelet peptide, arietin, from Bitis arietans venom. Huang TF; Wang WJ; Teng CM; Ouyang C Biochim Biophys Acta; 1991 May; 1074(1):144-50. PubMed ID: 2043664 [TBL] [Abstract][Full Text] [Related]
20. Generation and characterization of specific antibodies directed to the binding domain of adhesive molecules. Berliner SA; Roberts JR; Thorn ML; Ruggeri ZM Pept Res; 1988; 1(2):60-4. PubMed ID: 2485226 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]